Noida, India

M Umamaheshwar Prasad

USPTO Granted Patents = 1 



Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator of Angiotensin Receptor Blockers: M Umamaheshwar Prasad

Introduction: M Umamaheshwar Prasad is a notable inventor based in Noida, India. He has contributed significantly to the pharmaceutical field with a focus on the preparation of angiotensin receptor blockers. With a single patent to his name, he has made strides in reducing impurities in pharmaceutical compounds.

Latest Patents: Prasad's patent, titled "Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof," details a novel process for creating angiotensin receptor blockers, particularly Losartan and its potassium salt. His innovative method ensures that these compounds contain less than 10 parts per million (ppm) of azido impurities, which is crucial for maintaining the safety and effectiveness of medicinal products.

Career Highlights: Prasad's career is marked by his role in Jubilant Generics Limited, where he has applied his expertise to enhance pharmaceutical processes. His focus on creating a simple, economical, and industrially efficient method for producing Losartan potassium is a testament to his commitment to innovation in drug formulation.

Collaborations: Throughout his career, Prasad has worked alongside talented colleagues such as Saji Thomas and Rajendra Shekhawat. Their collaborative efforts have fostered an environment of innovation and technical advancement at Jubilant Generics Limited.

Conclusion: M Umamaheshwar Prasad stands out as a dedicated inventor in the pharmaceutical industry. His patented processes contribute significantly to the development of safer and more effective medications. With ongoing collaboration and innovation, Prasad continues to make a meaningful impact on the world of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…